Investigation of the aryl hydrocarbon receptor and the intrinsic tumoral component of the kynurenine pathway of tryptophan metabolism in primary brain tumors

No abstract is available for this paper.

• Publication year

  2018

• Venue

  Journal of Neuro-Oncology

• Publication date

  2018-04-17

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1007/s11060-018-2869-6PMID 29667084PMCID PMC6092214
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Role of the aryl hydrocarbon receptor in carcinogenesis and potential as an anti-cancer drug target

  2017cited by this paper
• Diffuse low-grade glioma: a review on the new molecular classification, natural history and current management strategies

  2017cited by this paper
• CBTRUS Statistical Report: Primary brain and other central nervous system tumors diagnosed in the United States in 2010–2014

  2017cited by this paper
• Kynurenine Pathway of Tryptophan Metabolism: Regulatory and Functional Aspects

  2017cited by this paper
• Indoleamine 2,3‐dioxygenase 1 (IDO1) inhibitors activate the aryl hydrocarbon receptor

  2017cited by this paper
• The Aryl Hydrocarbon Receptor (AhR) as a Drug Target for Cancer Chemotherapy.

  2017cited by this paper
• Therapeutic targeting of inflammation and tryptophan metabolism in colon and gastrointestinal cancer.

  2016cited by this paper
• Tryptophan PET Imaging of the Kynurenine Pathway in Patient-Derived Xenograft Models of Glioblastoma

  2016cited by this paper
• Epidemiology of Brain Tumors.

  2016cited by this paper
• Altered tryptophan metabolism in human meningioma

  2016cited by this paper
• Inhibiting tryptophan metabolism enhances interferon therapy in kidney cancer

  2016cited by this paper
• A TDO2-AhR signaling axis facilitates anoikis resistance and metastasis in triple-negative breast cancer.

  2015cited by this paper
• Genomic profiling of a Hepatocyte growth factor-dependent signature for MET-targeted therapy in glioblastoma

  2015cited by this paper
• Molecular imaging correlates of tryptophan metabolism via the kynurenine pathway in human meningiomas.

  2015cited by this paper
• Development of patient-derived xenograft models from a spontaneously immortal low-grade meningioma cell line, KCI-MENG1

  2015cited by this paper
• NIMG-38MULTIMODAL IMAGING OF SPATIAL PATTERNS OF POST-TREATMENT GLIOBLASTOMA PROGRESSION

  2015cited by this paper
• Understanding the role of the kynurenine pathway in human breast cancer immunobiology

  2015cited by this paper
• Omeprazole Inhibits Pancreatic Cancer Cell Invasion through a Nongenomic Aryl Hydrocarbon Receptor Pathway.

  2015cited by this paper
• Constitutive IDO expression in human cancer is sustained by an autocrine signaling loop involving IL-6, STAT3 and the AHR

  2014cited by this paper
• Involvement of the Kynurenine Pathway in Human Glioma Pathophysiology

  2014cited by this paper
• Circulating biomarkers of tryptophan and the kynurenine pathway and lung cancer risk.

  2014cited by this paper
• The activation mechanism of the aryl hydrocarbon receptor (AhR) by molecular chaperone HSP90

  2014cited by this paper
• Benzyl butyl phthalate induces migration, invasion, and angiogenesis of Huh7 hepatocellular carcinoma cells through nongenomic AhR/G-protein signaling

  2014cited by this paper
• Targeting adaptive glioblastoma: an overview of proliferation and invasion.

  2014cited by this paper
• Role of the aryl hydrocarbon receptor in carcinogenesis and potential as a drug target.

  2013cited by this paper
• Causes, consequences, and reversal of immune system aging.

  2013cited by this paper
• In vivo metabolism of tryptophan in meningiomas is mediated by indoleamine 2,3-dioxygenase 1

  2013cited by this paper
• The kynurenine system and immunoregulation

  2012cited by this paper
• Hydroxyurea for recurrent surgery and radiation refractory high-grade meningioma

  2012cited by this paper
• Tryptophan metabolism in breast cancers: molecular imaging and immunohistochemistry studies.

  2012cited by this paper
• CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2007-2011.

  2012cited by this paper
• Increased tryptophan transport in epileptogenic dysembryoplastic neuroepithelial tumors

  2012cited by this paper
• Systemic changes of tryptophan catabolites via the indoleamine-2,3-dioxygenase pathway in primary cervical cancer.

  2011cited by this paper
• An endogenous tumour-promoting ligand of the human aryl hydrocarbon receptor

  2011cited by this paper
• Hallmarks of cancer: the next generation.

  2011cited by this paper
• An Interaction between Kynurenine and the Aryl Hydrocarbon Receptor Can Generate Regulatory T Cells

  2010cited by this paper
• Kynurenic acid is a potent endogenous aryl hydrocarbon receptor ligand that synergistically induces interleukin-6 in the presence of inflammatory signaling.

  2010cited by this paper
• Advances in meningioma therapy

  2009cited by this paper
• Imaging Correlates of Differential Expression of Indoleamine 2,3-Dioxygenase in Human Brain Tumors

  2009cited by this paper
• Aryl hydrocarbon receptor inhibition downregulates the TGF-β/Smad pathway in human glioblastoma cells

  2009cited by this paper
• Aryl hydrocarbon receptor signaling mediates expression of indoleamine 2,3-dioxygenase.

  2008cited by this paper
• Hematoxylin and eosin staining of tissue and cell sections.

  2008cited by this paper
• Low-grade gliomas in adults

  2008cited by this paper
• The Combined Effects of Tryptophan Starvation and Tryptophan Catabolites Down-Regulate T Cell Receptor ζ-Chain and Induce a Regulatory Phenotype in Naive T Cells1

  2006cited by this paper
• Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma.

  2005cited by this paper
• Evidence for a tumoral immune resistance mechanism based on tryptophan degradation by indoleamine 2,3-dioxygenase

  2003cited by this paper
• Tryptophan-derived Catabolites Are Responsible for Inhibition of T and Natural Killer Cell Proliferation Induced by Indoleamine 2,3-Dioxygenase

  2002cited by this paper
• Endogenous kynurenines as targets for drug discovery and development

  2002cited by this paper
• Tryptophan nutrition and metabolism: an overview.

  1991cited by this paper

• Proteins and DNA Sequences Interacting with Tanshinones and Tanshinone Derivatives

  2025cites this paper
• Targeting the kynurenine pathway in gliomas: Insights into pathogenesis, therapeutic targets, and clinical advances.

  2025cites this paper
• Physiological and pathophysiological effects of L-tryptophan’s metabolites on the brain and immunity – a challenge for drug development

  2025cites this paper
• Tryptophan metabolism: From physiological functions to key roles and therapeutic targets in cancer (Review)

  2025cites this paper
• The differential role of aryl hydrocarbon receptor in skin cancers induced by environmental carcinogens, including ultraviolet irradiation, arsenic exposure, and HPV infection

  2025cites this paper
• IDO2-AhR axis as central regulator of the kynurenine pathway in glioblastoma

  2025cites this paper
• The Aryl Hydrocarbon Receptor in Neurotoxicity: An Intermediator Between Dioxins and Neurons in the Brain

  2025cites this paper
• Targeting the Kynureninase–HDAC6–Complement Axis as a Novel Therapeutic Strategy in Glioblastoma

  2025cites this paper
• Preliminary Results on the Added Value of Parametric Images Derived from 18F-fluoroethyl-L-tryptophan PET for Posttreatment Glioblastoma Assessment.

  2025cites this paper
• Integrated machine learning reveals the role of tryptophan metabolism in clear cell renal cell carcinoma and its association with patient prognosis

  2024cites this paper
• Characterizing the relationship between MRI radiomics and AHR expression and deriving a predictive model for prognostic assessment in glioblastoma

  2024cites this paper
• Tryptophan Metabolism Disorder-Triggered Diseases, Mechanisms, and Therapeutic Strategies: A Scientometric Review

  2024cites this paper
• Tumor Metabolism: A New Field for the Treatment of Glioma.

  2024cites this paper
• Prognostic relevance of high expression of kynurenine pathway markers in glioblastoma

  2024cites this paper
• Amino acid metabolic reprogramming in the tumor microenvironment and its implication for cancer therapy

  2024cites this paper
• Metabolic Barriers to Glioblastoma Immunotherapy

  2023influential citation
• Tryptophan metabolism in health and disease.

  2023cites this paper
• The First Human Application of an F-18-Labeled Tryptophan Analog for PET Imaging of Cancer

  2023cites this paper
• Glioblastoma and Methionine Addiction

  2022cites this paper
• HLA-G and Other Immune Checkpoint Molecules as Targets for Novel Combined Immunotherapies

  2022cites this paper
• Rutaecarpine Inhibits U87 Glioblastoma Cell Migration by Activating the Aryl Hydrocarbon Receptor Signaling Pathway

  2021cites this paper
• Tryptophan metabolism in brain tumors - IDO and beyond.

  2021cites this paper
• Current Challenges for IDO2 as Target in Cancer Immunotherapy

  2021cites this paper
• Immune Checkpoints in Pediatric Solid Tumors: Targetable Pathways for Advanced Therapeutic Purposes

  2021cites this paper
• Skin biological responses to urban pollution in an ex vivo model.

  2021cites this paper
• Metabolic Remodeling in Glioma Immune Microenvironment: Intercellular Interactions Distinct From Peripheral Tumors

  2021cites this paper
• Tryptophan metabolism is inversely regulated in the tumor and blood of patients with glioblastoma

  2021cites this paper
• The aryl hydrocarbon receptor: a diagnostic and therapeutic target in glioma.

  2021cites this paper
• Indoleamine 2,3-Dioxygenase 1: A Promising Therapeutic Target in Malignant Tumor

  2021cites this paper
• Depression and tryptophan metabolism in patients with primary brain tumors: Clinical and molecular imaging correlates

  2020cites this paper
• TDO Promotes Hepatocellular Carcinoma Progression

  2020cites this paper
• Immunosuppressive IDO in Cancer: Mechanisms of Action, Animal Models, and Targeting Strategies

  2020cites this paper
• Indoleamine 2,3-Dioxygenase 2 Immunohistochemical Expression in Resected Human Non-small Cell Lung Cancer: A Potential New Prognostic Tool

  2020cites this paper
• Advantages of gross total resection in patients with astrocytoma: A population-based study

  2020cites this paper
• The Role of Aryl Hydrocarbon Receptor (AhR) in Brain Tumors

  2020influential citation
• Both IDO1 and TDO contribute to the malignancy of gliomas via the Kyn–AhR–AQP4 signaling pathway

  2020cites this paper
• OTT_A_252929 5845..5855

  2020cites this paper
• Multimodal neuroimaging of gliomatosis cerebri: a case series of four patients

  2020cites this paper
• Depression and tryptophan metabolism in patients with primary brain tumors: Clinical and molecular imaging correlates

  2020cites this paper
• Omeprazole Inhibits Glioblastoma Cell Invasion and Tumor Growth

  2020cites this paper
• Modulation of glioma-inflammation crosstalk profiles in human glioblastoma cells by indirubin-3'-(2,3 dihydroxypropyl)-oximether (E804) and 7-bromoindirubin-3'-oxime (7BIO).

  2019cites this paper
• Non-NF2 mutations have a key effect on inhibitory immune checkpoints and tumor pathogenesis in skull base meningiomas

  2019cites this paper
• The aryl hydrocarbon receptor is a tumor suppressor–like gene in glioblastoma

  2019cites this paper
• The Effects of Indirubin Derivative E804 on Inflammatory Profiles in Glioblastoma Multiforme Cell Lines and Subsequent Crosstalk Effect on Tumor Associated THP-1 Macrophages

  2019cites this paper
• Aryl-Hydrocarbon Receptor as a Potential Target for Anticancer Therapy

  2018cites this paper
• Inflammatory breast cancer: Activation of the aryl hydrocarbon receptor and its target CYP1B1 correlates closely with Wnt5a/b-β-catenin signalling, the stem cell phenotype and disease progression

  2018cites this paper